ATMPs (Cell and Gene Therapy) Challenges and Opportunities for this Emerging Modality and Panel Discussion

Speaker(s):

• James A. Breen, PE, Vice President, Lead Biologics Expansion, Janssen Pharmaceuticals
• Frances M. Zipp, President & CEO, Lachman Consultant Services
• Ryan Larson, Ph.D., Senior Director, Cell Therapy Product and Analytical Development, Bristol Myers Squibb
• Kathy Francissen, Ph.D., Executive Director, Biologics Development, CMC Regulatory, Genentech
• Steven Oh, Ph.D., Deputy Director, Division of Cellular and Gene Therapies, FDA/CBER/OTAT
• Stefanos Grammatikos, Ph.D., Vice President – Head of Biotech Sciences, UCB Pharma (Belgium) /UCB Celltech (UK)